Tracheostomies after SARS-CoV-2 intubation, performed by academic otorhinolaryngologists in the Paris area of France : Preliminary results
Copyright © 2021 Elsevier Masson SAS. All rights reserved..
OBJECTIVE: To analyse tracheostomies after intubation for SARS-Cov-2 infection performed by otorhinolaryngologists in 7 university hospitals in the Paris area of France during the month March 24 to April 23, 2020.
MATERIAL AND METHODS: A multicentre retrospective observational study included 59 consecutive patients. The main goals were to evaluate the number, characteristics and practical conditions of tracheostomies, and the COVID-19 status of the otorhinolaryngologists. Secondary goals were to analyse tracheostomy time, decannulation rate, immediate postoperative complications and laryngotracheal axis status.
RESULTS: Tracheostomy indications were for ventilatory weaning and extubation failure in 86% and 14% of cases, respectively. The technique was surgical, percutaneous or hybrid in 91.5%, 3.4% and 5.1% of cases, respectively. None of the operators developed symptoms consistent with COVID-19. Postoperative complications occurred in 15% of cases, with no significant difference between surgical and percutaneous/hybrid techniques (P=0.33), although no complications occurred after percutaneous or hybrid tracheostomies. No procedures or complications resulted in death. The decannulation rate was 74.5% with a mean tracheostomy time of 20±12 days. In 55% of the patients evaluated by flexible endoscopy after decannulation, a laryngeal abnormality was found. On univariate analysis, no clinical features had a significant influence on tracheostomy time, decannulation rate or occurrence of laryngeal lesions.
CONCLUSION: The main findings of the present retrospective study were: absence of contamination of the surgeons, heterogeneity of practices between centres, a high rate of complications and laryngeal lesions whatever the technique, and the specificities of the patients.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:138 |
|---|---|
| Enthalten in: |
European annals of otorhinolaryngology, head and neck diseases - 138(2021), 6 vom: 12. Dez., Seite 443-449 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bartier, S [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
France |
|---|
| Anmerkungen: |
Date Completed 04.11.2021 Date Revised 02.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.anorl.2021.03.002 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32263962X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32263962X | ||
| 003 | DE-627 | ||
| 005 | 20231225182452.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.anorl.2021.03.002 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1075.xml |
| 035 | |a (DE-627)NLM32263962X | ||
| 035 | |a (NLM)33707069 | ||
| 035 | |a (PII)S1879-7296(21)00049-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bartier, S |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tracheostomies after SARS-CoV-2 intubation, performed by academic otorhinolaryngologists in the Paris area of France |b Preliminary results |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.11.2021 | ||
| 500 | |a Date Revised 02.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a OBJECTIVE: To analyse tracheostomies after intubation for SARS-Cov-2 infection performed by otorhinolaryngologists in 7 university hospitals in the Paris area of France during the month March 24 to April 23, 2020 | ||
| 520 | |a MATERIAL AND METHODS: A multicentre retrospective observational study included 59 consecutive patients. The main goals were to evaluate the number, characteristics and practical conditions of tracheostomies, and the COVID-19 status of the otorhinolaryngologists. Secondary goals were to analyse tracheostomy time, decannulation rate, immediate postoperative complications and laryngotracheal axis status | ||
| 520 | |a RESULTS: Tracheostomy indications were for ventilatory weaning and extubation failure in 86% and 14% of cases, respectively. The technique was surgical, percutaneous or hybrid in 91.5%, 3.4% and 5.1% of cases, respectively. None of the operators developed symptoms consistent with COVID-19. Postoperative complications occurred in 15% of cases, with no significant difference between surgical and percutaneous/hybrid techniques (P=0.33), although no complications occurred after percutaneous or hybrid tracheostomies. No procedures or complications resulted in death. The decannulation rate was 74.5% with a mean tracheostomy time of 20±12 days. In 55% of the patients evaluated by flexible endoscopy after decannulation, a laryngeal abnormality was found. On univariate analysis, no clinical features had a significant influence on tracheostomy time, decannulation rate or occurrence of laryngeal lesions | ||
| 520 | |a CONCLUSION: The main findings of the present retrospective study were: absence of contamination of the surgeons, heterogeneity of practices between centres, a high rate of complications and laryngeal lesions whatever the technique, and the specificities of the patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a France | |
| 650 | 4 | |a Otorhinolaryngology | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Tracheostomy | |
| 700 | 1 | |a La Croix, C |e verfasserin |4 aut | |
| 700 | 1 | |a Evrard, D |e verfasserin |4 aut | |
| 700 | 1 | |a Hervochon, R |e verfasserin |4 aut | |
| 700 | 1 | |a Laccourreye, O |e verfasserin |4 aut | |
| 700 | 1 | |a Gasne, C |e verfasserin |4 aut | |
| 700 | 1 | |a Excoffier, A |e verfasserin |4 aut | |
| 700 | 1 | |a Tanaka, L |e verfasserin |4 aut | |
| 700 | 1 | |a Barry, B |e verfasserin |4 aut | |
| 700 | 1 | |a Coste, A |e verfasserin |4 aut | |
| 700 | 1 | |a Tankere, F |e verfasserin |4 aut | |
| 700 | 1 | |a Kania, R |e verfasserin |4 aut | |
| 700 | 1 | |a Nevoux, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European annals of otorhinolaryngology, head and neck diseases |d 2010 |g 138(2021), 6 vom: 12. Dez., Seite 443-449 |w (DE-627)NLM201398648 |x 1879-730X |7 nnns |
| 773 | 1 | 8 | |g volume:138 |g year:2021 |g number:6 |g day:12 |g month:12 |g pages:443-449 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.anorl.2021.03.002 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 138 |j 2021 |e 6 |b 12 |c 12 |h 443-449 | ||